JP2023524061A5 - - Google Patents

Info

Publication number
JP2023524061A5
JP2023524061A5 JP2022566315A JP2022566315A JP2023524061A5 JP 2023524061 A5 JP2023524061 A5 JP 2023524061A5 JP 2022566315 A JP2022566315 A JP 2022566315A JP 2022566315 A JP2022566315 A JP 2022566315A JP 2023524061 A5 JP2023524061 A5 JP 2023524061A5
Authority
JP
Japan
Prior art keywords
seq
mutation
polypeptide
vector system
aav9
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2022566315A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023524061A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/030298 external-priority patent/WO2021222831A2/en
Publication of JP2023524061A publication Critical patent/JP2023524061A/ja
Publication of JP2023524061A5 publication Critical patent/JP2023524061A5/ja
Withdrawn legal-status Critical Current

Links

JP2022566315A 2020-05-01 2021-04-30 操作された中枢神経系用組成物 Withdrawn JP2023524061A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063019221P 2020-05-01 2020-05-01
US63/019,221 2020-05-01
US202063061517P 2020-08-05 2020-08-05
US63/061,517 2020-08-05
PCT/US2021/030298 WO2021222831A2 (en) 2020-05-01 2021-04-30 Engineered central nervous system compositions

Publications (2)

Publication Number Publication Date
JP2023524061A JP2023524061A (ja) 2023-06-08
JP2023524061A5 true JP2023524061A5 (https=) 2024-05-13

Family

ID=78373993

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022566315A Withdrawn JP2023524061A (ja) 2020-05-01 2021-04-30 操作された中枢神経系用組成物

Country Status (7)

Country Link
US (1) US20230193316A1 (https=)
EP (1) EP4143305A4 (https=)
JP (1) JP2023524061A (https=)
CN (1) CN115867646A (https=)
AU (1) AU2021264061A1 (https=)
CA (1) CA3176506A1 (https=)
WO (1) WO2021222831A2 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113166208B (zh) 2018-10-02 2024-11-22 沃雅戈治疗公司 重新定向aav衣壳的嗜性
TWI900553B (zh) 2020-05-13 2025-10-11 美商航海家醫療公司 Aav蛋白殼之趨性重定向
US20240115734A1 (en) * 2021-02-09 2024-04-11 Affinia Therapeutics Inc. Recombinant aavs with improved tropism and specificity
CA3216419A1 (en) * 2021-04-23 2022-10-27 Greg NACHTRAB Tissue-targeted modified aav capsids and methods of use thereof
WO2022226375A1 (en) * 2021-04-23 2022-10-27 Locanabio, Inc. Tissue-targeted modified aav capsids and methods of use thereof
KR20240095539A (ko) 2021-10-08 2024-06-25 디노 테라퓨틱스, 인코포레이티드 캡시드 변이체 및 이의 사용 방법
EP4426716A1 (en) 2021-11-02 2024-09-11 Voyager Therapeutics, Inc. Aav capsid variants and uses thereof
US20260085284A1 (en) * 2022-08-30 2026-03-26 Shanghai Genemagic Biosciences Co., Ltd. Method for trans-differentiating non-neuronal cells into neurons and use thereof
WO2024086747A1 (en) 2022-10-19 2024-04-25 Affinia Therapeutics Inc. Recombinant aavs with improved tropism and specificity
WO2024191778A1 (en) 2023-03-10 2024-09-19 Dyno Therapeutics, Inc. Capsid polypeptides and methods of use thereof
WO2024238807A2 (en) 2023-05-16 2024-11-21 Affinia Therapeutics Inc. Recombinant aavs with improved tropism and specificity
TW202516019A (zh) * 2023-06-29 2025-04-16 賓州大學委員會 具中樞神經系統靶向模體的突變aav及含有其之組成物
AU2024332181A1 (en) 2023-08-31 2026-02-12 Dyno Therapeutics, Inc. Capsid polypeptides and methods of use thereof
CN117165677A (zh) * 2023-11-03 2023-12-05 首都儿科研究所 检测生物标志物在制备神经管畸形疾病的产品的应用
WO2025160155A1 (en) 2024-01-22 2025-07-31 The Broad Institute, Inc. Epigenetic targeting of prion diseases
TW202545971A (zh) 2024-02-08 2025-12-01 美商戴諾治療公司 殼體多肽及其使用方法
WO2026064442A2 (en) 2024-09-18 2026-03-26 Dyno Therapeutics, Inc. Capsid polypeptides and methods of use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160039877A1 (en) * 2013-03-15 2016-02-11 Shenzhen Hightide Biopharmaceutical, Ltd. Compositions and methods of using islet neogenesis peptides and analogs thereof
EP4344741A3 (en) * 2014-11-21 2024-08-28 The University of North Carolina at Chapel Hill Aav vectors targeted to the central nervous system
BR112017022845A2 (pt) * 2015-04-23 2018-07-17 Nantomics, Llc neoepítopos de câncer
KR102423442B1 (ko) * 2015-12-11 2022-07-20 캘리포니아 인스티튜트 오브 테크놀로지 아데노-관련 바이러스를 지시하기 위한 타겟팅 펩타이드
US12043848B2 (en) * 2017-10-16 2024-07-23 Vigeneron Gmbh AAV vectors
CA3100006A1 (en) * 2018-05-11 2019-11-14 Massachusetts Eye And Ear Infirmary Altering tissue tropism of adeno-associated viruses
WO2020028751A2 (en) * 2018-08-03 2020-02-06 Voyager Therapeutics, Inc. Aav variants with enhanced tropism
CN113166208B (zh) * 2018-10-02 2024-11-22 沃雅戈治疗公司 重新定向aav衣壳的嗜性
WO2023039480A2 (en) * 2021-09-08 2023-03-16 The Broad Institute, Inc. Engineered central nervous system compositions

Similar Documents

Publication Publication Date Title
JP2023524061A5 (https=)
JP2023534999A5 (https=)
EP1135468B1 (en) Virus vectors and methods of making and administering the same
JP2022551986A5 (https=)
JP2024514956A5 (https=)
JP6174318B2 (ja) アデノ随伴ウイルス構築物を含んでなるコンダクティング気道細胞を標的とするための組成物
JP2021512649A5 (https=)
JP2022068181A5 (https=)
JP2025500347A5 (https=)
CN107864653B (zh) 衣壳
JP2022529631A5 (https=)
IL273261B2 (en) Adeno-associated virus variant capsids and methods of using them
JP2020511127A5 (https=)
US20050106558A1 (en) Library of modified structural genes or capsid modified particles useful for the identification of viral clones with desired cell tropism
JP2018148927A5 (https=)
JP2024099770A5 (https=)
JP2007507223A5 (https=)
JP2021523702A5 (https=)
JP2024530023A5 (https=)
JP7541027B2 (ja) 筋肉発現のためのハイブリッドプロモーター
JP2023551873A5 (https=)
JP2023537358A5 (https=)
JP2021531044A5 (https=)
JP2023529371A5 (https=)
JP2021534766A5 (https=)